MWOGX
Price
$50.67
Change
+$0.15 (+0.30%)
Updated
Jul 25 closing price
Net Assets
961.92M
RPEBX
Price
$69.03
Change
+$0.06 (+0.09%)
Updated
Jul 25 closing price
Net Assets
158.35B
Interact to see
Advertisement

MWOGX vs RPEBX

Header iconMWOGX vs RPEBX Comparison
Open Charts MWOGX vs RPEBXBanner chart's image
MFS Global Growth R1
Price$50.67
Change+$0.15 (+0.30%)
VolumeN/A
Net Assets961.92M
American Funds New Perspective R2E
Price$69.03
Change+$0.06 (+0.09%)
VolumeN/A
Net Assets158.35B
MWOGX vs RPEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MWOGX vs. RPEBX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MWOGX is a Buy and RPEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPEBX has more cash in the bank: 158B vs. MWOGX (962M). RPEBX pays higher dividends than MWOGX: RPEBX (0.12) vs MWOGX (0.00). MWOGX was incepted earlier than RPEBX: MWOGX (20 years) vs RPEBX (11 years). MWOGX (2.07) is less costly to investors than RPEBX (1.21). RPEBX (24.00) and MWOGX (23.00) have comparable annual turnover. MWOGX has a lower initial minimum investment than RPEBX: MWOGX (0) vs RPEBX (250). RPEBX annual gain was more profitable for investors over the last year : 16.37 vs. MWOGX (3.47). RPEBX return over 5 years is better than : 39.67 vs. MWOGX (20.90).
MWOGXRPEBXMWOGX / RPEBX
Total Expense Ratio1.971.21163%
Annual Report Gross Expense Ratio2.071.21171%
Fund Existence20 years11 years-
Gain YTD6.36014.34544%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets962M158B1%
Annual Yield % from dividends0.000.12-
Returns for 1 year3.4716.3721%
Returns for 3 years20.2443.3947%
Returns for 5 years20.9039.6753%
Returns for 10 years64.7879.9481%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACRV1.430.04
+2.88%
Acrivon Therapeutics
SERV11.650.25
+2.19%
Serve Robotics
UBER91.290.42
+0.46%
Uber Technologies
SERA3.25N/A
N/A
Sera Prognostics
ETNB9.59-0.39
-3.91%
89bio